As shown in Fig. 7A, the treatment with this drug combination efficiently reversed the expression of anti-apoptotic BCL2 protein and pro-apoptotic BIM protein in LOUCY ETP-ALL cell line expressing ZEB2. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.